Home

STEVEN REICHLING

CIK 1556290 · Chief Financial Officer · last filed 2023-03-15

STEVEN REICHLING is a Chief Financial Officer who has filed 30 SEC Form 4 insider transactions across 1 company since 2015. The most recent filing, for AXDX, was dated Mar 15, 2023. Across all open-market trades the lifetime net is −$2.2M, making them a net seller over the disclosed history.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

1

Total Filings

30

Lifetime Open-Market Net

-$2.24M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Accelerate Diagnostics, Inc (AXDX) Delisted Chief Financial Officer 147,078 $0.03 $5.0K -$2.24M 29 2023-03-15

Recent Filings

30 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2023-03-15 Accelerate Diagnostics, Inc (AXDX) Delisted Mixed +4,730 -$2.3K EDGAR
2023-03-13 Accelerate Diagnostics, Inc (AXDX) Delisted Mixed +60,822 -$29.5K EDGAR
2023-02-15 Accelerate Diagnostics, Inc (AXDX) Delisted Mixed +4,616 -$2.9K EDGAR
2023-01-17 Accelerate Diagnostics, Inc (AXDX) Delisted Mixed +4,709 -$3.3K EDGAR
2022-08-22 Accelerate Diagnostics, Inc (AXDX) Delisted Buy (P) +5,000 $6.9K EDGAR
2022-04-28 Accelerate Diagnostics, Inc (AXDX) Delisted Mixed +27,821 -$29.3K EDGAR
2022-04-06 Accelerate Diagnostics, Inc (AXDX) Delisted Grant (A) — $0 EDGAR
2022-03-30 Accelerate Diagnostics, Inc (AXDX) Delisted Grant (A) — $0 EDGAR
2021-05-14 Accelerate Diagnostics, Inc (AXDX) Delisted Mixed +19,089 -$56.1K EDGAR
2021-03-16 Accelerate Diagnostics, Inc (AXDX) Delisted Grant (A) — $0 EDGAR
Showing 1–10 of 30
Page 1 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.